Glaxosmithkline Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Sep '25
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Total Qtr Revenue cr
    1,013.51
    848.89
    1,015.05
    984.49
    1,045.31
    Other Income Qtr Cr33.5743.7240.6835.0734.54
    Operating Revenues Qtr979.94805.17974.37949.421,010.77
    Loading chart...
    Operating Expenses Qtr
    644.21
    553.97
    641.18
    657.50
    689.06
    Operating Profit Qtr
    335.73
    251.20
    333.19
    291.92
    321.71
    EBITDA Qtr Cr
    371.94
    294.92
    373.87
    326.99
    360.94
    Depreciation Qtr
    17.43
    15.52
    14.72
    18.80
    16.86
    Net Profit Qtr
    257.49
    205.01
    262.87
    229.88
    252.50
    Basic EPS Qtr
    15.20
    12.10
    15.52
    13.57
    14.91
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -